Literature DB >> 24227712

Changes in brain function occur years before the onset of cognitive impairment.

Lori L Beason-Held1, Joshua O Goh, Yang An, Michael A Kraut, Richard J O'Brien, Luigi Ferrucci, Susan M Resnick.   

Abstract

To develop targeted intervention strategies for the treatment of Alzheimer's disease, we first need to identify early markers of brain changes that occur before the onset of cognitive impairment. Here, we examine changes in resting-state brain function in humans from the Baltimore Longitudinal Study of Aging. We compared longitudinal changes in regional cerebral blood flow (rCBF), assessed by (15)O-water PET, over a mean 7 year period between participants who eventually developed cognitive impairment (n = 22) and those who remained cognitively normal (n = 99). Annual PET assessments began an average of 11 years before the onset of cognitive impairment in the subsequently impaired group, so all participants were cognitively normal during the scanning interval. A voxel-based mixed model analysis was used to compare groups with and without subsequent impairment. Participants with subsequent impairment showed significantly greater longitudinal rCBF increases in orbitofrontal, medial frontal, and anterior cingulate regions, and greater longitudinal decreases in parietal, temporal, and thalamic regions compared with those who maintained cognitive health. These changes were linear in nature and were not influenced by longitudinal changes in regional tissue volume. Although all participants were cognitively normal during the scanning interval, most of the accelerated rCBF changes seen in the subsequently impaired group occurred within regions thought to be critical for the maintenance of cognitive function. These changes also occurred within regions that show early accumulation of pathology in Alzheimer's disease, suggesting that there may be a connection between early pathologic change and early changes in brain function.

Entities:  

Mesh:

Year:  2013        PMID: 24227712      PMCID: PMC3828456          DOI: 10.1523/JNEUROSCI.1402-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  The effects of age on the neural correlates of episodic encoding.

Authors:  C L Grady; A R McIntosh; M N Rajah; S Beig; F I Craik
Journal:  Cereb Cortex       Date:  1999-12       Impact factor: 5.357

Review 2.  Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI.

Authors:  M Jueptner; C Weiller
Journal:  Neuroimage       Date:  1995-06       Impact factor: 6.556

Review 3.  Functional neuroimaging studies of prospective memory: what have we learnt so far?

Authors:  Paul W Burgess; Gil Gonen-Yaacovi; Emmanuelle Volle
Journal:  Neuropsychologia       Date:  2011-02-15       Impact factor: 3.139

4.  Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.

Authors:  Ira Driscoll; Susan M Resnick; Juan C Troncoso; Yang An; Richard O'Brien; Alan B Zonderman
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

5.  Altered default-mode network activation in mild cognitive impairment compared with healthy aging.

Authors:  Frederick De Vogelaere; Patrick Santens; Erik Achten; Paul Boon; Guy Vingerhoets
Journal:  Neuroradiology       Date:  2012-04-12       Impact factor: 2.804

6.  Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice.

Authors:  Yaisa Andrews-Zwilling; Nga Bien-Ly; Qin Xu; Gang Li; Aubrey Bernardo; Seo Yeon Yoon; Daniel Zwilling; Tonya Xue Yan; Ligong Chen; Yadong Huang
Journal:  J Neurosci       Date:  2010-10-13       Impact factor: 6.167

Review 7.  Structural and functional MRI in mild cognitive impairment.

Authors:  Maija Pihlajamäki; Anne M Jauhiainen; Hilkka Soininen
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

8.  Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease.

Authors:  Maija Pihlajamäki; Kelly O' Keefe; Lars Bertram; Rudolph E Tanzi; Bradford C Dickerson; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

9.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

Review 10.  Neuropathology of Alzheimer's disease.

Authors:  Daniel P Perl
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb
View more
  62 in total

1.  Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.

Authors:  Wenna Duan; Parshant Sehrawat; Arvind Balachandrasekaran; Ashish B Bhumkar; Paresh B Boraste; James T Becker; Lewis H Kuller; Oscar L Lopez; H Michael Gach; Weiying Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  Insights into Computational Drug Repurposing for Neurodegenerative Disease.

Authors:  Manish D Paranjpe; Alice Taubes; Marina Sirota
Journal:  Trends Pharmacol Sci       Date:  2019-07-17       Impact factor: 14.819

4.  Frontal, Striatal, and Medial Temporal Sensitivity to Value Distinguishes Risk-Taking from Risk-Aversive Older Adults during Decision Making.

Authors:  Joshua O S Goh; Yu-Shiang Su; Yong-Jheng Tang; Anna C McCarrey; Alexander Tereshchenko; Wendy Elkins; Susan M Resnick
Journal:  J Neurosci       Date:  2016-12-07       Impact factor: 6.167

5.  Cerebral blood flow MRI in the nondemented elderly is not predictive of post-operative delirium but is correlated with cognitive performance.

Authors:  Tammy T Hshieh; Weiying Dai; Michele Cavallari; Charles Rg Guttmann; Dominik S Meier; Eva M Schmitt; Bradford C Dickerson; Daniel Z Press; Edward R Marcantonio; Richard N Jones; Yun Ray Gou; Thomas G Travison; Tamara G Fong; Long Ngo; Sharon K Inouye; David C Alsop
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 6.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

7.  Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.

Authors:  Jeremy A Elman; Matthew S Panizzon; Daniel E Gustavson; Carol E Franz; Mark E Sanderson-Cimino; Michael J Lyons; William S Kremen
Journal:  Biol Psychiatry       Date:  2020-01-07       Impact factor: 13.382

8.  Regulating effect of CBF on memory in cognitively normal older adults with different ApoE genotype: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Junyang Wang; Guoping Peng; Ping Liu; Xufei Tan; Benyan Luo
Journal:  Cogn Neurodyn       Date:  2019-05-11       Impact factor: 5.082

Review 9.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

10.  SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.

Authors:  Sahba Seddighi; Vijay R Varma; Yang An; Sudhir Varma; Lori L Beason-Held; Toshiko Tanaka; Melissa H Kitner-Triolo; Michael A Kraut; Christos Davatzikos; Madhav Thambisetty
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.